MAKO Weakness Viewed as Buying Opportunity and 3 Stock Analyses Making Rounds

| + More Articles
  • Like on Facebook
  • Share on Google+
  • Share on LinkedIn

AeroVironment, Inc. (NASDAQ:AVAV) is predicted by BB&T to see benefits resulting from the high priority that the Pentagon places on small unmanned aircraft. The firm continues to be convinced that the company possesses the inside track on a $248 million, five year unmanned aircraft deal slated to be announced in only a few weeks. The firm keeps its Outperform rating on the stock.

Dole Food Company Inc. (NYSE:DOLE): Since Dole Food’s chairman, David Murdock, has now taken the position of CEO and now the company’s former general counsel has become its COO, BB&T has been curious about whether or not Murdock intends to  pursue an LBO. The firm still keeps its Hold rating on the stock.

Catalysts are critical to discovering winning stocks. Check out our newest CHEAT SHEET stock picks now.

MAKO Surgical Corp. (NASDAQ:MAKO): Piper Jaffray has stated that the weakness in the company’s shares following Blue Belt’s NavioPFS orthopedic surgery system received FDA approval as a buying opportunity. Piper thinks predicts that it could be a lengthy time for NavioPFS to build momentum, but the firm has also stated that the approval indicates competition for MAKO in the U.S. The firm recommends buying shares on MAKO on today’s weakness, and it keeps its Overweight rating on the stock.

Medivation, Inc. (NASDAQ:MDVN): According to JPMorgan, Johnson & Johnson’s (NYSE:JNJ) Zytega approval is a positive for Medivation.

Don’t Miss: McDonald’s to Analysts: You Got Served!

More Articles About:

To contact the reporter on this story: To contact the editor responsible for this story:

Yahoo Finance, Harvard Business Review, Market Watch, The Wall St. Journal, Financial Times, CNN Money, Fox Business